Unlock the future of diagnostics with the Immunohistochemistry market, projected to soar from $3.1 billion in 2023 to $5.5 billion by 2031, growing at a robust 7.4% CAGR! Experience innovation across ...
Moonwalk will present new data highlighting its epigenetic capabilities in identifying new therapeutic targets for metabolic diseases and liver disorders using its proprietary EpiRead™ and EpiWrite™ ...
Today, on 21 October 2024, ExpreS2ion Biotech Holding AB ("ExpreS2ion" or the "Company") has held an Extraordinary General Meeting 2024 (the "EGM"). Notice of the EGM and complete proposals for resolu ...